Trade.xyz launched a perpetual futures contract on the Hyperliquid blockchain tied to the expected share price of Chinese memory-chip maker ChangXin Memory Technologies (CXMT). The contract arrived ahead of CXMT’s expected IPO on July 27.
Key Takeaways
- Trade.xyz’s Hyperliquid contract traded near $8.4, implying a market value near $560 billion versus CXMT’s official valuation.
- CXMT is scheduled to list on July 27 on the Shanghai Stock Exchange, according to Reuters, a debut set to be Asia’s largest IPO so far this year.
- Hyperliquid priced the new $CXMT ticker at 500 HYPE, about $32,625, per Hyperliquid’s own announcement, far below the 500,000 HYPE stake a deployer needs to run a HIP-3 perp market.
- CXMT set its Shanghai STAR Market offer at RMB8.66 per share, per CXMT’s own pricing filing, aiming to raise about $8.55 billion before any over allotment.
- Individual investors need at least RMB 500,000 and two years of trading experience to buy STAR Market shares directly, per Shanghai’s STAR Market rules.
Trade.xyz Deploys a Synthetic CXMT Market on Hyperliquid
Hyperliquid’s IPOP market now carries the new $CXMT ticker, launched ahead of CXMT’s expected IPO, according to Hyperliquid. Hyperliquid said the new listing will therefore launch in IPOP once the ticker was secured.
Onchain data tracked by traders shows the synthetic contract trading at $8.4, which implies a market value near $560 billion, more than six times the $85 billion CXMT is expected to carry at its official offer price. The perpetual gives synthetic price exposure only, with no shares, no dividend rights and no vote in CXMT.
NEW HIP-3 TICKER$CXMT has been acquired for 500 $HYPE ($32,625).
— Hyperliquid News (@HyperliquidNews) July 14, 2026
The ticker is intended for CXMT, a Chinese memory chip manufacturer, ahead of its expected IPO on July 27, and will therefore launch in IPOP. pic.twitter.com/7gc3qu42wj
CXMT’s Actual IPO, by the Numbers
CXMT priced its Shanghai STAR Market offering at RMB8.66 per share and will offer 6.69 billion shares. The sale is expected to raise about RMB57.9 billion, or $8.55 billion, before any over-allotment option, and the price implies a 2025 diluted price-to-earnings ratio of 308.92 times.
The listing is set to be Asia’s largest IPO so far this year and the biggest Chinese A-share semiconductor offering since Semiconductor Manufacturing International Corp.’s 2020 debut. CXMT, founded in 2016, is the world’s fourth-largest DRAM chipmaker, with roughly a 7.7 percent market share in 2025.
How HIP-3 Turns a Named Company Into a Tradable Ticker?
Hyperliquid’s HIP-3 framework lets any deployer that meets a 500,000 HYPE staking requirement launch a perpetual market without approval from any centralized authority, and the deployer sets the oracle price, leverage limits and settlement terms once the market is live.
Coin Metrics’ State of the Network report found the framework has accumulated about $290 billion in cumulative trading volume and $3 billion in open interest across its equity, index and commodity perpetuals.
Its prior pre-IPO markets have tracked real prices closely. Hyperliquid’s Cerebras Systems perpetual settled roughly 1.3% above the eventual cash open, and its SpaceX market has carried more than $250 million in open interest. Measured against that record, CXMT’s premium looks less like a forecast of where the shares will open and more like a sign of thin, one-sided demand for a name most buyers cannot reach any other way.
A Synthetic Route Around China’s STAR Market Gate
China’s STAR Market restricts direct participation. Individual investors need an account balance of at least RMB 500,000 and two years of securities trading experience before they can trade listed shares, and CXMT’s Shanghai listing is largely limited to onshore investors and remains difficult for many global investors to buy directly. Hyperliquid’s contract sidesteps that gate entirely: Trade.xyz deployed it without CXMT’s involvement, and the company collects none of the resulting trading volume.
That gap sits in unsettled legal territory. A permissionless, deployer defined derivative on a named company’s stock, launched with no issuer consent and no central operator to hold accountable. No regulator has signed off on the product, and a trader who buys the $CXMT perpetual takes leveraged exposure to a price that can swing on thin synthetic liquidity, for reasons that have nothing to do with CXMT’s actual business.
CoinLaw’s Takeaway
This launch reads as a structural workaround, not a CXMT corporate event. Hyperliquid’s HIP-3 framework lets anyone holding enough HYPE wrap a synthetic price around a company that never asked for the exposure, and the access gap on decentralized exchanges like Hyperliquid is exactly what that structure is built to fill. If the implied $560 billion valuation collapses toward CXMT’s cash price the way the Cerebras contract did once shares actually list later in 2026, it confirms the market was pricing scarce access rather than CXMT itself.
The bigger pattern deserves the closer watch. HIP-3 keeps outperforming skepticism on price accuracy, even as it keeps outrunning the rules meant to govern who can reference a company’s stock price before that company ever asks to be listed. A derivative that trades a name without the company’s involvement, on a chain with no central operator to hold to account, is the kind of product regulators and exchanges alike are still working out how to classify.
